latin-america-header

LATIN AMERICA

We have an established history of more than 10 years in Latin America. Mexico and Brazil account for almost 80% of the revenue generated in the region. Our expanded regional coverage gives us a presence Colombia, Chile, Ecuador, Costa Rica, Peru and Argentina. Our comprehensive product range encompasses in branded prescription and OTC products.

Key Countries

Brazil,
Chile,
Colombia,
Ecuador,
Mexico

Contribution to Group revenue

pic-7europe

Revenue contribution - by therapeutic category

pic-8europe
  • The Spanish Latin American private pharmaceutical sector grew 4.3% in value for the year to 31 August 2019 as compared to the prior period
  • The Brazilian private pharmaceutical market declined 7% and was valued by IMS at USD28 billion for the year to 30 June 2019, negatively impacted by foreign exchange

Source: June 2019 IQVIA

STATISTICS

Number of products launched:

8

(2018: 6)#

In-market sales value of pipeline as at 30 June 2019 anticipated to be launched in:

0 – 2 years

USD426 million

3 – 5 years

USD493 million

Number of product recalls:

Nil

(2018: 2)

Average staff turnover:

24,9%

(2018: 22,8%)

Number of work-related fatalities:

Nil

(2018: Nil)

Number of permanent employees:

june-04

Revenue2019
R'million
2018 (CER)
R'million
change
%
Total3 0832 910 6
Regional Brands2 1142 0016
Sterile Focus Brands9699097
Anaesthetics Brands8948357
Thrombosis Brands7574 1

Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.